Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet

Hormone and Metabolic Research

Volumn 39, Issue 4, 2007, Pages 262-267

  Wang, C ^a   Yang, N ^a   Wu, S ^a   Liu, L ^a   Sun, X ^a   Nie, S ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Caloric intake; Dietary induced obesity; Energy efficiency; High fat diet; Hypothalamus; Neuropeptide Y; NPY receptor; Obesity

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENERGY YIELD; FEMALE; GENE EXPRESSION; HYPOTHALAMUS; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIET; DIETARY FATS; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HYPOTHALAMUS; NEUROPEPTIDE Y; OBESITY; RADIOIMMUNOASSAY; RATS; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WEIGHT GAIN;

RATTUS;

EID: 34248210587     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973073     Document Type: Article

References (31)

1. West DB, York B: Dietary fat, genetic predisposition and obesity: lessons from animal models. Am J Clin Nutr 1998; 67: 505-512
2. Fehm HL, Born J, Peters A: Glucocorticoids and melanocortins in the regulation of body weight in humans. Horm Metab Res 2004; 36: 360-364
3. Leibowitz SF, Alexander J, Dourmashkin JT, Hill JO, Gayles EC, Chang GQ: Phenotypic profile of SWR/J and A/J mice as compared to control strains: possible mechanisms underlying resistance to obesity on a high-fat diet. Brain Res 2005; 1047: 137-147
4. Larhammar D: Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 1966; 65: 165-174
5. Tulipano G, Vergoni AV, Soldi D, Muller EE, Cocchi D: Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rat fed a high-fat diet. J Endocrinol 2004; 183: 289-298
6. Melanie H, Lorraine G, Jun G, Joyce JH: Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes Res 2005; 13: 36-47
7. Chantacha A, Alexandra R, John ME, Iain C: Expression of NPY and POMC in the hypothalamic arcuate nucleus of genetically lean and fat sheep. Front Neuroendocrinology 2006; 27: 9-10
8. Allen YS, Adiran TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM: Neuropeptide Y distribution in the rat brain. Science 1983; 221: 877-879
9. Martin CM, Annette BS, Helen C, Henri ND, Herbert H, Dan L, Remi Q, Thue S, Thomas W: International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998; 50: 143-150
10. Popovic V, Duntas LH: Leptin TRH and ghrelin: influence on energy homeostasis at rest and during exercise. Horm Metab Res 2005; 37: 533-537
11. Dumont Y, Jacques D, St-Pierre JA, Tong Y, Parker R, Herzog H, Quirion R: Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNA in mammalian brains. J Chem Neuroanat 2000; 16: 375-475
12. Tentolouris N, Kokkinos A, Tsigos C, Kyriaki D, Doupis J, Raptis SA, Katsilambros N: Differential effects of high-fat and high-carbohydrate content isoenergetic meals on plasma active ghrelin concentrations in lean and obese women. Horm Metab Res 2004; 36: 559-563
13. Parker E, Van Heek M, Stamford A: Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 2002; 440: 173-187
14. Holmberg KS, Johnson AE, Bergqvist C, Källström L, Larhammar D: Localization of neuropeptide Y receptor Y5 mRNA in guinea pig brain by in situ hybridization. Regul Pept 2004; 117: 61-67
15. Roche C, Boutin P, Dina C, Gyapay G, Basdevant A, Hager J, Guy-Grand B, Clement K, Froguel P: Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity. Diabetologia 1997; 40: 671-675
16. Levin BE, Sullivan AC: Glucose-induced norepinephrine levels and obesity resistance. Am J Physiol 1987; 253: R475-R481
17. Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG: Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes 1997; 46: 1792-1798
18. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
19. Beck B: Intracerebroventricular injection of proinsulin C-peptide does not influence food consumption in male long-Evans rats. Horm Metab Res 2006; 38: 314-316
20. White BD, Martin RJ: Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 1997; 214: 222-232
21. Yang NH, Wang CJ, Xu MJ, Mao LM, Liu LG, Sun XF: Interaction of Dietary Composition and PYY Gene Expression in Diet-induced Obesity in Rat. J Huazhong Univ Sci Technolog [Med Sci] 2005; 25: 243-246
22. Chang S, Graham B, Yakubu F, Lin D, Peters JC, Hill JO: Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 1990; 259: 1103-1110
23. Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H: Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med 2004; 229: 486-493
24. Levin BE, Dumm-Meynell AA: Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats. Am J Physiol 1997; 272: 1365-1370
25. Bergen HT, Mizuno T, Taylor J, Mobbs CV: Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus. Brain Res 1999; 851: 198-203
26. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H: Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 2002; 99: 8938-8943
27. Batterham RL, Cohen MA, Ellis SM, Leroux CW, Withers DJ, Frost GS. Ghatei MA, Bloom SR: Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-948
28. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR: Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006; 147: 3-8
29. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-654
30. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ: Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006; 4: 223-233
31. Henry M, Ghibaudi L, Gao J, Hwa JJ: Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes Res 2005; 13: 36-47